BioSpace News Archive

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced an agreement with a Blues plan in Hawaii.

Regen Lab, a Swiss commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue engineering products announces that its US subsidiary, RegenLab USA LLC, has entered into a collaboration agreement with Long Island University (LIU) and the Dassault Systèmes Group (3DS).

Forward Pharma A/S (OTC:FWPAY) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of its ordinary shares represented by American Depositary Shares (“ADSs”), issued by the Bank of New York Mellon as depositary, from 14 ordinary shares per ADS to 4000 ordinary shares per ADS.

NeuroMetrix, Inc. (Nasdaq: NURO) noted presentation of new clinical data at the Diabetes UK meeting held April 23-26 in Liverpool, UK.

Cogent Biosciences, Inc. today announced its participation in a fireside chat at the Jefferies Healthcare Conference in New York on Thursday, June 8, 2023 at 9:30 a.m. ET.

Baudax Bio, Inc. today announced additional results from its Phase 2 clinical trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery.

In her late 50s, Marion’s doctor found a cancerous wart that required an intense six weeks of radiation therapy, coupled with chemotherapy.

The National Cancer Institute -designated Montefiore Einstein Cancer Center has received a five-year, $2.9 million grant from the NCI to train physicians and scientists to conduct clinical and translational oncology research, with a special emphasis on investigating and addressing health inequities in the Bronx.

Lunaphore and Cell Signaling Technology announced a partnership to enable the use of CST® antibodies on the Lunaphore COMET™ platform, a scalable hyperplex imaging solution for fully automated spatial biology.

Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the “Company”), a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines,